Big pharma: CVS sells major debt dose as bankers pin hopes on M&A
CVS Health printed the third-biggest bond deal of all time as it funded its $67.5bn acquisition of Aetna. Bankers hope that a revival in M&A activity will provide a shot in the arm for supply.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: